Clostridium 2017-2021: Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

December 2016 | 225 pages | ID: C6854CBA24FEN
Venture Planning Group

Abstracts

The report presents a detailed analysis of the Clostridium diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Clostridium definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments

• Hospitals
• Commercial/Private Labs
• Physician Offices
• Public Health Labs

The report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 225 pages and 8 tables

Contents

I. INTRODUCTION

II. Clostridium WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. France: Test Volume and Diagnostics Sales Forecast by Market Segment
IV. Germany: Test Volume and Diagnostics Sales Forecast by Market Segment
V. Italy: Test Volume and Diagnostics Sales Forecast by Market Segment
VI. Japan: Test Volume and Diagnostics Sales Forecast by Market Segment
VII. Spain: Test Volume and Diagnostics Sales Forecast by Market Segment
VIII. UK: Test Volume and Diagnostics Sales Forecast by Market Segment
IX. USA: Test Volume and Diagnostics Sales Forecast by Market Segment

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized

TESTING MARKETS

  1. MARKETING APPROACHES
  2. PRODUCT COMPLEXITY
  3. CUSTOMER PREFERENCE
  4. ESTABLISHED SUPPLIERS
  5. EMERGING SUPPLIERS
  6. MAJOR TYPES OF DISTRIBUTORS
  7. MARKET SEGMENTATION

XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
BioRad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/GenProbe
ID Biomedical/GSK
Kreatech/Leica
Lonza
OrthoClinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
France: Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
Germany: Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
Italy: Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
Japan: Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
Spain: Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.: Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.: Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment